Companies

ArriVent BioPharma, Inc.

AVBP · CIK 0001868279 · operating

$23.18+0.91%Last updated Mar 3, 12:10 AM

Key Statistics

Valuation

Market Cap$956.90M
P/E
Fwd P/E-5.90
PEG
P/S
P/B3.10
EV/EBITDA
EV/Rev

Profitability

Gross Margin
Op. Margin
Net Margin
ROE-31.24%
ROA-29.27%
FCF Margin

Financial Health

Current Ratio13.14
Debt/Equity0.07
Free Cash Flow-$70.21M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth
Beta1.00
52W High$26
52W Low$15.47

About ArriVent BioPharma, Inc.

ArriVent BioPharma, Inc. (AVBP) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $957 million, ArriVent BioPharma, Inc. is a small-cap company. The stock currently trades at $23.18, up 0.91% today, with a 52-week range of $15.47–$26.00.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-2.56$-2.56

Annual Reports (10-K) · 2 filings

Report DateFiledAccession Number
2024-12-312025-03-030001558370-25-001999SEC ↗
2023-12-312024-03-280001558370-24-004280SEC ↗